VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10046363 | HBV | ENSG00000138798.13 | protein_coding | EGF | No | No | 1950 | P01133 |
TVIS30003680 | HIV | ENSG00000138798.13 | protein_coding | EGF | No | No | 1950 | P01133 |
TVIS30086078 | HIV | ENSG00000138798.13 | protein_coding | EGF | No | No | 1950 | P01133 |
TVIS30060843 | HIV | ENSG00000138798.13 | protein_coding | EGF | No | No | 1950 | P01133 |
TVIS20041723 | HPV | ENSG00000138798.13 | protein_coding | EGF | No | No | 1950 | P01133 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | EGF |
---|---|
DrugBank ID | DB00364 |
Drug Name | Sucralfate |
Target ID | BE0000953 |
UniProt ID | P01133 |
Regulation Type | inducer |
PubMed IDs | 8578218; 1957124; 1970337 |
Citations | Tarnawski A, Tanoue K, Santos AM, Sarfeh IJ: Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment? Scand J Gastroenterol Suppl. 1995;210:9-14.@@Szabo S: The mode of action of sucralfate: the 1 x 1 x 1 mechanism of action. Scand J Gastroenterol Suppl. 1991;185:7-12.@@Konturek SJ: Role of growth factors in gastroduodenal protection and healing of peptic ulcers. Gastroenterol Clin North Am. 1990 Mar;19(1):41-65. |
Groups | Approved |
Direct Classification | |
SMILES | O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O |
Pathways | |
PharmGKB | PA451524 |
ChEMBL | CHEMBL2029132 |